Free Trial

Arrowstreet Capital Limited Partnership Boosts Stock Position in Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Arrowstreet Capital Limited Partnership raised its holdings in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1,061.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 85,790 shares of the business services provider's stock after purchasing an additional 78,401 shares during the quarter. Arrowstreet Capital Limited Partnership owned 0.17% of Exponent worth $7,644,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in EXPO. Vanguard Group Inc. increased its stake in Exponent by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider's stock worth $476,284,000 after buying an additional 67,296 shares during the period. State Street Corp boosted its position in Exponent by 0.7% in the 3rd quarter. State Street Corp now owns 1,840,313 shares of the business services provider's stock valued at $212,151,000 after buying an additional 13,644 shares during the period. Geode Capital Management LLC grew its stake in Exponent by 4.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider's stock worth $173,597,000 after acquiring an additional 69,099 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after acquiring an additional 245,086 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in shares of Exponent during the fourth quarter valued at approximately $55,131,000. 92.37% of the stock is owned by hedge funds and other institutional investors.

Exponent Trading Up 1.7 %

Shares of NASDAQ EXPO traded up $1.32 during trading hours on Friday, reaching $80.32. The stock had a trading volume of 307,072 shares, compared to its average volume of 242,311. Exponent, Inc. has a 52-week low of $73.83 and a 52-week high of $115.75. The firm has a market cap of $4.08 billion, a price-to-earnings ratio of 37.89 and a beta of 0.84. The business's fifty day moving average price is $83.53 and its two-hundred day moving average price is $93.26.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period in the previous year, the business posted $0.41 earnings per share. Equities research analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the transaction, the vice president now directly owns 1,800 shares of the company's stock, valued at $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 2.10% of the stock is owned by insiders.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines